How can Machine Learning be used to identify depression in patients with gynecological cancers – ASCO
American Society of Clinical Oncology (ASCO) shared a post on LinkedIn:
“How can Machine Learning be used to identify depression in patients with gynecological cancers? ASCO Expert in AI Dr. Julian Hong explains ASCOBT24 research on using voice recordings to screen for depression and how it’s a good first step for bringing technology into the cancer clinic.
See the science.”
Proceed to the video attached to the post.
Source: ASCO/LinkedIn
More posts by ASCO in OncoDaily.
The American Society of Clinical Oncology (ASCO) is a leading professional organization representing nearly 45,000 physicians and oncology specialists worldwide, dedicated to cancer care.
Founded in 1964 by Fred Ansfield, Harry Bisel, Herman Freckman, Arnoldus Goudsmit, Robert Talley, William Wilson, and Jane C. Wright, ASCO is committed to advancing cancer research, education, prevention, and high-quality patient care.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023